Investors' Impax Drug Price-Fixing Suit Fails Again
A California federal judge on Monday again dismissed a shareholder suit alleging generic-drug maker Impax Laboratories Inc. failed to disclose to investors a federal investigation over possibly collusive market activity, finding...To view the full article, register now.
Already a subscriber? Click here to view full article